Bridgeway Capital Management, LLC Tenaya Therapeutics, Inc. Transaction History
Bridgeway Capital Management, LLC
- $4.24 Billion
- Q4 2024
A detailed history of Bridgeway Capital Management, LLC transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 228,400 shares of TNYA stock, worth $274,080. This represents 0.01% of its overall portfolio holdings.
Number of Shares
228,400
Previous 235,500
3.01%
Holding current value
$274,080
Previous $454,000
28.19%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding TNYA
# of Institutions
93Shares Held
55.6MCall Options Held
900Put Options Held
104K-
Column Group LLC San Francisco, CA9.4MShares$11.3 Million24.12% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$8.08 Million0.83% of portfolio
-
Jpmorgan Chase & CO New York, NY5.16MShares$6.19 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$4.89 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.27MShares$3.93 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $49.6M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...